BAYER AG-REG (BAYN.DE) Fundamental Analysis & Valuation

FRA:BAYN • DE000BAY0017

Current stock price

38.635 EUR
-0.5 (-1.27%)
Last:

This BAYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BAYN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BAYN was profitable.
  • In the past year BAYN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BAYN reported negative net income in multiple years.
  • BAYN had a positive operating cash flow in each of the past 5 years.
BAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B -10B

1.2 Ratios

  • BAYN's Return On Assets of -3.46% is on the low side compared to the rest of the industry. BAYN is outperformed by 67.31% of its industry peers.
  • With a Return On Equity value of -13.95%, BAYN is not doing good in the industry: 67.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.46%
ROE -13.95%
ROIC N/A
ROA(3y)-2.76%
ROA(5y)-0.83%
ROE(3y)-10.29%
ROE(5y)-3.43%
ROIC(3y)N/A
ROIC(5y)N/A
BAYN.DE Yearly ROA, ROE, ROICBAYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • In the last couple of years the Operating Margin of BAYN has declined.
  • Looking at the Gross Margin, with a value of 58.76%, BAYN is doing worse than 63.46% of the companies in the same industry.
  • BAYN's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BAYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.76%
OM growth 3Y-2.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y1.79%
BAYN.DE Yearly Profit, Operating, Gross MarginsBAYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1

2. BAYN.DE Health Analysis

2.1 Basic Checks

  • BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BAYN has about the same amount of shares outstanding.
  • BAYN has about the same amout of shares outstanding than it did 5 years ago.
  • BAYN has a better debt/assets ratio than last year.
BAYN.DE Yearly Shares OutstandingBAYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
BAYN.DE Yearly Total Debt VS Total AssetsBAYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • BAYN has an Altman-Z score of 0.76. This is a bad value and indicates that BAYN is not financially healthy and even has some risk of bankruptcy.
  • BAYN has a Altman-Z score of 0.76. This is in the lower half of the industry: BAYN underperforms 71.15% of its industry peers.
  • BAYN has a debt to FCF ratio of 10.93. This is a negative value and a sign of low solvency as BAYN would need 10.93 years to pay back of all of its debts.
  • The Debt to FCF ratio of BAYN (10.93) is worse than 63.46% of its industry peers.
  • BAYN has a Debt/Equity ratio of 1.23. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.23, BAYN is doing worse than 71.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 10.93
Altman-Z 0.76
ROIC/WACCN/A
WACC6.92%
BAYN.DE Yearly LT Debt VS Equity VS FCFBAYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • BAYN has a Current Ratio of 1.01. This is a normal value and indicates that BAYN is financially healthy and should not expect problems in meeting its short term obligations.
  • BAYN has a Current ratio of 1.01. This is in the lower half of the industry: BAYN underperforms 76.92% of its industry peers.
  • A Quick Ratio of 0.63 indicates that BAYN may have some problems paying its short term obligations.
  • BAYN has a worse Quick ratio (0.63) than 82.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.63
BAYN.DE Yearly Current Assets VS Current LiabilitesBAYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

3

3. BAYN.DE Growth Analysis

3.1 Past

  • The earnings per share for BAYN have decreased by -2.77% in the last year.
  • The Earnings Per Share has been decreasing by -5.13% on average over the past years.
  • Looking at the last year, BAYN shows a decrease in Revenue. The Revenue has decreased by -2.21% in the last year.
  • Measured over the past years, BAYN shows a small growth in Revenue. The Revenue has been growing by 1.94% on average per year.
EPS 1Y (TTM)-2.77%
EPS 3Y-14.8%
EPS 5Y-5.13%
EPS Q2Q%-40.95%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-3.51%
Revenue growth 5Y1.94%
Sales Q2Q%-2.48%

3.2 Future

  • Based on estimates for the next years, BAYN will show a small growth in Earnings Per Share. The EPS will grow by 4.13% on average per year.
  • Based on estimates for the next years, BAYN will show a small growth in Revenue. The Revenue will grow by 2.62% on average per year.
EPS Next Y-4.68%
EPS Next 2Y1.69%
EPS Next 3Y6.34%
EPS Next 5Y4.13%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BAYN.DE Yearly Revenue VS EstimatesBAYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
BAYN.DE Yearly EPS VS EstimatesBAYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

6

4. BAYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.87, which indicates a rather cheap valuation of BAYN.
  • BAYN's Price/Earnings ratio is rather cheap when compared to the industry. BAYN is cheaper than 98.08% of the companies in the same industry.
  • BAYN is valuated cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 8.25 indicates a reasonable valuation of BAYN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 98.08% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. BAYN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.87
Fwd PE 8.25
BAYN.DE Price Earnings VS Forward Price EarningsBAYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BAYN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BAYN is more expensive than 63.46% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BAYN is valued cheaply inside the industry as 88.46% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.04
EV/EBITDA 38.69
BAYN.DE Per share dataBAYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.69%
EPS Next 3Y6.34%

0

5. BAYN.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.28%, BAYN is not a good candidate for dividend investing.
  • BAYN's Dividend Yield is slightly below the industry average, which is at 1.94.
  • Compared to an average S&P500 Dividend Yield of 1.89, BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.28%

5.2 History

  • The dividend of BAYN decreases each year by -46.01%.
Dividend Growth(5Y)-46.01%
Div Incr Years0
Div Non Decr Years3
BAYN.DE Yearly Dividends per shareBAYN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.51%
EPS Next 2Y1.69%
EPS Next 3Y6.34%
BAYN.DE Yearly Income VS Free CF VS DividendBAYN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B -10B

BAYN.DE Fundamentals: All Metrics, Ratios and Statistics

BAYER AG-REG

FRA:BAYN (3/13/2026, 7:00:00 PM)

38.635

-0.5 (-1.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-04
Earnings (Next)05-12
Inst Owners51.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap37.96B
Revenue(TTM)45.58B
Net Income(TTM)-3.62B
Analysts73.1
Price Target42.36 (9.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.28%
Yearly Dividend0.13
Dividend Growth(5Y)-46.01%
DP-3.51%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.61%
Min EPS beat(2)22.06%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)35.24%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.01%
EPS beat(12)9
Avg EPS beat(12)9.7%
EPS beat(16)12
Avg EPS beat(16)8.09%
Revenue beat(2)1
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-2.42%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.34%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)0.67%
Revenue beat(8)3
Avg Revenue beat(8)-1.37%
Revenue beat(12)3
Avg Revenue beat(12)-2.43%
Revenue beat(16)6
Avg Revenue beat(16)-1.51%
PT rev (1m)0%
PT rev (3m)29.98%
EPS NQ rev (1m)4.97%
EPS NQ rev (3m)5.52%
EPS NY rev (1m)-4.2%
EPS NY rev (3m)-3.83%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 7.87
Fwd PE 8.25
P/S 0.83
P/FCF 11.04
P/OCF 6.41
P/B 1.46
P/tB N/A
EV/EBITDA 38.69
EPS(TTM)4.91
EY12.71%
EPS(NY)4.68
Fwd EY12.11%
FCF(TTM)3.5
FCFY9.06%
OCF(TTM)6.03
OCFY15.61%
SpS46.39
BVpS26.41
TBVpS-23.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number54.02
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -13.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.76%
FCFM 7.54%
ROA(3y)-2.76%
ROA(5y)-0.83%
ROE(3y)-10.29%
ROE(5y)-3.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.98%
ROCE(5y)8.08%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y1.79%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 10.93
Debt/EBITDA 18.64
Cap/Depr 89.3%
Cap/Sales 5.46%
Interest Coverage N/A
Cash Conversion 346.9%
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.63
Altman-Z 0.76
F-Score6
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)49.46%
Cap/Depr(5y)55.83%
Cap/Sales(3y)5.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.77%
EPS 3Y-14.8%
EPS 5Y-5.13%
EPS Q2Q%-40.95%
EPS Next Y-4.68%
EPS Next 2Y1.69%
EPS Next 3Y6.34%
EPS Next 5Y4.13%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-3.51%
Revenue growth 5Y1.94%
Sales Q2Q%-2.48%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%
EBIT growth 1Y-1416.9%
EBIT growth 3Y-5.49%
EBIT growth 5YN/A
EBIT Next Year55.31%
EBIT Next 3Y16.4%
EBIT Next 5Y10.93%
FCF growth 1Y-25.07%
FCF growth 3Y-6.06%
FCF growth 5Y6.77%
OCF growth 1Y-19.56%
OCF growth 3Y-5.83%
OCF growth 5Y3.89%

BAYER AG-REG / BAYN.DE Fundamental Analysis FAQ

What is the fundamental rating for BAYN stock?

ChartMill assigns a fundamental rating of 2 / 10 to BAYN.DE.


What is the valuation status of BAYER AG-REG (BAYN.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.


How profitable is BAYER AG-REG (BAYN.DE) stock?

BAYER AG-REG (BAYN.DE) has a profitability rating of 1 / 10.


How financially healthy is BAYER AG-REG?

The financial health rating of BAYER AG-REG (BAYN.DE) is 1 / 10.


How sustainable is the dividend of BAYER AG-REG (BAYN.DE) stock?

The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -3.51%.